Drug Utilization Review Board

The Drug Utilization Review (DUR) Board serves in an advisory capacity to the Department of Health Care Policy and Financing and makes recommendations regarding issues of drug utilization, provider education interventions, and application of standards.  The DUR Board also determines the prior authorization criteria for drugs with special prescribing guidelines and the prior authorization criteria for non-preferred drugs, those that don't make the Preferred Drug List (PDL).

Want to know what the DUR team has been up to? Check out our first newsletter!


Reasonable accommodations for the meetings will be provided upon request for persons with disabilities.  Please contact the Program Administrator at least one week prior to the scheduled meeting if you need special arrangements.